Raymond James Financial Inc. bought a new stake in shares of Transcat, Inc. (NASDAQ:TRNS - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 19,587 shares of the scientific and technical instruments company's stock, valued at approximately $2,071,000. Raymond James Financial Inc. owned approximately 0.21% of Transcat at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in TRNS. Jones Financial Companies Lllp grew its holdings in shares of Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after buying an additional 309 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Transcat by 8.8% during the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company's stock worth $557,000 after purchasing an additional 373 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of Transcat by 1.4% during the fourth quarter. Victory Capital Management Inc. now owns 34,710 shares of the scientific and technical instruments company's stock worth $3,670,000 after purchasing an additional 480 shares during the last quarter. Rhumbline Advisers grew its position in shares of Transcat by 4.1% in the fourth quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company's stock valued at $1,306,000 after purchasing an additional 486 shares during the period. Finally, Diamond Hill Capital Management Inc. increased its stake in Transcat by 11.7% in the fourth quarter. Diamond Hill Capital Management Inc. now owns 6,143 shares of the scientific and technical instruments company's stock valued at $650,000 after purchasing an additional 643 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on TRNS shares. Northland Securities reissued a "market perform" rating and issued a $85.00 target price (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Oppenheimer cut shares of Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. HC Wainwright reduced their target price on Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a report on Wednesday, January 29th. Finally, StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $111.50.
Get Our Latest Stock Report on Transcat
Transcat Stock Performance
TRNS stock traded up $0.17 during trading on Friday, reaching $79.82. 75,768 shares of the company's stock were exchanged, compared to its average volume of 75,658. The firm has a market cap of $743.04 million, a PE ratio of 43.15 and a beta of 0.69. The company's fifty day moving average price is $76.88 and its 200-day moving average price is $92.79. Transcat, Inc. has a 1-year low of $67.56 and a 1-year high of $147.12. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.
Transcat Company Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
